NYLIM
PRLB icon

New York Life Investment Management’s Protolabs PRLB Stock Holding History

New York Life Investment Management’s Portfolio PRLB Stock Details PRLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,378
Closed -$371K – 1206
2024
Q1 		$371K Sell
10,378
-120
-1% -$4.33K ﹤0.01% 956
2023
Q4 		$409K Sell
10,498
-242
-2% -$7.84K ﹤0.01% 976
2023
Q3 		$284K Sell
10,740
-1,692
-14% -$51.1K ﹤0.01% 1188
2023
Q2 		$435K Sell
12,432
-2,632
-17% -$83.9K ﹤0.01% 871
2023
Q1 		$499K Buy
+15,064
New +$466K 0.01% 677

Other funds holding PRLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York Life Investment Management's PRLB Position: Q2 2024 in Review

New York Life Investment Management sold out of Protolabs (PRLB) in Q2 2024, closing a stake of 10,378 shares — an estimated $371K sold.

New York Life Investment Management first reported a position in PRLB in Q1 2023 and held it in 5 quarters. The position peaked at $499K in Q1 2023. 204 funds tracked by Wall St. Rank hold PRLB as of Q2 2024.

  • New York Life Investment Management reported no remaining Protolabs position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 10,378 Protolabs shares in Q2 2024, an estimated $371K.
  • New York Life Investment Management first reported a position in Protolabs in Q1 2023 and held it in 5 quarters.
  • New York Life Investment Management's Protolabs position peaked at $499K in Q1 2023.
  • 204 funds tracked by Wall St. Rank held Protolabs as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.